59.95亿元资金流向：人工智能与医疗器械融资活跃，千寻位置完成超10亿元B轮融资｜21私募投融资周报

Group 1 - The core focus of recent financing activities is on artificial intelligence and medical devices, with significant investments in technology and manufacturing sectors [1] - Core Medical completed over $100 million in Series D financing, marking the largest investment in China's innovative medical device sector since 2025 [1][17] - Qianxun Positioning Network Co., Ltd. secured over 1 billion RMB in Series B financing, indicating strong investor interest in spatial intelligence technology [1][22] Group 2 - A total of 48 financing events occurred in the domestic primary market from April 21 to April 27, with disclosed amounts exceeding 59.95 billion RMB [2] - The majority of financing cases were in the technology and manufacturing sectors, particularly in artificial intelligence, robotics, and medical devices [4][5] - Guangdong, Zhejiang, and Shanghai were the leading regions for financing activities, with 11, 9, and 8 cases respectively [6][7] Group 3 - Active investment institutions included Bohua Capital, which invested in three companies, and Junlian Capital, which participated in two financing rounds [8][9] - Notable financing cases included: - Core Medical's Series D financing of over $100 million [17] - A+ round financing of over 100 million RMB for Changde Medical [16] - Series C financing of nearly 100 million RMB for Aopeng Medical [13] Group 4 - The financing landscape shows a diverse range of applications in robotics, with companies focusing on smart care, industrial, and general service sectors [1] - The medical health sector also demonstrated robust activity, with multiple financing rounds for medical devices and biopharmaceuticals [1][4] - The trend indicates a growing interest in AI-driven solutions for healthcare and manufacturing, reflecting broader technological advancements [1][22]